However, other evidence revealed that cancer immunotherapy targeting CD47 can induce cancer cells to leak mtDNA into nearby dendritic cells and present antigens to effector T cells, bridging the innate and adaptive immune systems [122]. This evidence concerns the gene CD47 and cancer.